🇮🇳 Zydus Lifesciences Ltd
Get Zydus Lifesciences Ltd filings on Telegram the moment they are published.
Follow Zydus Lifesciences Ltd on TelegramOne tap starts your 30-day free trial. No card needed.
Overview: USFDA has accepted the Biologics License Application for FYB206, a Keytruda biosimilar developed by Zydus and Formycon, for review with a decision expected Q3 2027.
Get filings like this in Telegram the moment they are published — for the companies you follow.
Start 30-day trial About Finterest